6-Ethyl-1,2-dihydropyridine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 6-Ethyl-1,2-dihydropyridine
• 化学式: C₇H₁₁N
• 分子量: 109.17
• InChiKey: WORWDKZEXZNFLE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] SUBSTITUTED 4-AZAINDOLES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS<br/>[FR] 4-AZAINDOLES SUBSTITUÉS ET LEUR UTILISATION COMME MODULATEURS DU RÉCEPTEUR DE GLUN2B
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2017007938A1

  公开（公告）日：2017-01-12

  Substituted 4-azaindoles as NR2B receptor ligands. Such compounds may be used in NR2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by NR2B receptor activity.

  将4-氮杂吲哚作为NR2B受体配体。这类化合物可用于NR2B受体调节以及用于治疗由NR2B受体活性介导的疾病状态、紊乱和病况的药物组合物和方法。
• CLASS OF NEAR INFRARED OPTICAL PROBES FOR BIOLOGICAL APPLICATIONS
  申请人：Pang Yi

  公开号：US20140080168A1

  公开（公告）日：2014-03-20

  2,5-Bis(benzoxazol-2′-yl)benzene-1,4-diol derivatives (Zinhbo derivatives) are used to detect zinc ions and have particular application in vivo and in vitro. Zinhbo derivatives upon excitation give a florescence response emission that can be used to determine the presence of zinc cation in solution. Zinhbo derivatives complexed with zinc cations upon excitation can produce a florescence response emission in the visible and near infrared range. Zinhbo derivatives complexed with zinc cations exhibit a large stoke shift between the excitation and emission wavelengths.

  2,5-双(苯并噁唑-2′-基)苯-1,4-二酚衍生物（Zinhbo衍生物）用于检测锌离子，在体内和体外具有特殊应用。激发后，Zinhbo衍生物会发出荧光响应发射，可用于确定溶液中锌阳离子的存在。与锌阳离子络合后，Zinhbo衍生物在激发时可以在可见光和近红外范围内产生荧光响应发射。与锌阳离子络合的Zinhbo衍生物在激发和发射波长之间表现出较大的斯托克位移。
• Viral polymerase inhibitors
  申请人：Boehringer Ingelheim International GmbH

  公开号：EP2626354A1

  公开（公告）日：2013-08-14

  An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.

  式 I 所代表化合物的对映体、非对映异构体或同系物： 其中 A、B、R1、R2、R3、R4、R5、R6、R7、R8、R9 和 R10 如本文所定义，或其盐或酯，作为 HCV NS5B 聚合酶的抑制剂。
• QUINAZOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
  申请人：Arromax Pharmatech Co., Ltd.

  公开号：EP3181553A1

  公开（公告）日：2017-06-21

  Disclosed are a quinazoline derivative, a preparation method therefor, and a pharmaceutical composition and an application thereof. The present invention provides a compound represented by general formula I, a stereoisomer thereof and a pharmaceutical acceptable salt or a solvate thereof. The quinazoline derivative of the present invention has a unique chemical structure, is characterized by irreversibly inhibiting EGFR tyrosine kinase, has high biological activity, apparently improves the inhibiting effect on the EGFR tyrosine kinase, has quite strong tumor inhibiting effect on tumor cells and a transplantation tumor pathological model of animal tumors, and has good market developing prospects.

  本发明公开了一种喹唑啉衍生物、其制备方法、药物组合物及其应用。本发明提供了一种通式 I 所代表的化合物、其立体异构体及其药用盐或溶液。本发明的喹唑啉衍生物具有独特的化学结构，以不可逆地抑制表皮生长因子受体酪氨酸激酶为特征，具有较高的生物活性，明显提高了对表皮生长因子受体酪氨酸激酶的抑制作用，对肿瘤细胞和移植瘤病理模型动物肿瘤具有相当强的抑瘤作用，具有良好的市场发展前景。
• SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF
  申请人：Xiamen Vivohealths Technology Co., Ltd.

  公开号：EP3608312A1

  公开（公告）日：2020-02-12

  Disclosed in the invention are a type of compounds having aldolase selective inhibitory activity, a method for the preparation thereof, a pharmaceutical composition comprising the same, and use of these compounds in the manufacture of a medicament for inhibiting triglyceride and cholesterol synthesis, for reducing fatty acid synthesis, for preventing and/or treating obesity and type II diabetes, for preventing and/or treating tumor, for preventing and/or treating Parkinson's disease, for preventing and/or treating Alzheimer's disease or for prolonging the lifespan of mammals:

  本发明公开了一种具有醛缩酶选择性抑制活性的化合物、其制备方法、包含这些化合物的药物组合物，以及这些化合物在制造用于抑制甘油三酯和胆固醇合成、减少脂肪酸合成、预防和/或治疗肥胖症和II型糖尿病、预防和/或治疗肿瘤、预防和/或治疗帕金森病、预防和/或治疗阿尔茨海默病或延长哺乳动物寿命的药物中的用途：